Nav: Home

Xeno/endobiotic metabolism potencies vary between strains and sex in rats

February 20, 2019

In pharmaceutical companies, rats are used commonly in nonclinical studies to investigate the safety, efficacy, and pharmacokinetic profiles of drug candidates before they are entered into clinical studies. Most compounds administered via the oral route are metabolized in the liver and intestine, so the metabolism is a key determinant of pharmacokinetics.

The uridine 5'-diphospho-glucuronosyltransferase (Ugt) superfamily is one of the major groups of drug-metabolizing enzymes. They catalyze the glucuronidation of compounds to increase their water solubility and enhance their excretion through bile and urine. Ugt isoforms, categorized into Ugt1 or Ugt2 families, show different (but sometimes overlapping) substrate specificity. To understand or predict the potential for glucuronidation, information about the abundance and metabolic potencies of each Ugt isoform is required. Most importantly, quantitative evaluation of Ugts in rats has not been carried out.

To address the issue, Miki Nakajima and colleagues at Kanazawa University (Kanazawa, Japan) measured the absolute mRNA expression of Ugts in the liver and small intestine of male and female Sprague-Dawley (SD), Fischer 344 (F344), and Wistar rats by quantitative reverse transcription-polymerase chain reaction. In rats, there are eight Ugt1a isoforms (Ugt1a1, 2, 3, 5, 6, 7, 8, and 10) and seven Ugt2b isoforms (Ugt2b1, 2, 3, 6, 8, 12, and 34). The sum of mRNA expression of Ugts expressed in the liver was 2-6-fold higher than that in the small intestine regardless of the strain or sex of rats. In the liver, expression of Ugt2b mRNA represented ~80% of total expression of Ugt mRNA whereas, in the small intestine, expression of Ugt1a mRNA accounted for ~90%.

Particularly interesting data were obtained for expression of Ugts in different rat strains. Ugt2b2 was expressed specifically in the livers of Wistar rats, and resulted in twofold higher expression of total hepatic Ugt mRNA in Wistar rats than that in the other strains tested. This difference in expression between rat strains would result in differences in the glucuronidation of androsterone, lithocholic acid, and triiodothyronine, and substrates of Ugt2b2 between rat strains. Differences between strains were also observed in intestinal Ugts. Ugt2b3 expression was prominently higher in the small intestine of Wistar rats than that in the other strains tested. Ugt2b3 catalyzes the glucuronidation of aromatic primary amines. Therefore, differences in rat strains with regard to intestinal expression of Ugt2b3 could contribute to differences in rat strains in terms of drug pharmacokinetics. Therefore, Nakajima et al. provided a helpful clue for the selection of rat strains, showing that Ugt expression in Wistar rats was different from that in the other strains tested.

Hepatic expression of Ugt1a10 was significantly higher in females than in males in all strains (though the copy number was much lower than that for other isoforms) evaluated. In Wistar rats, the sum of hepatic expression of the Ugt2b isoform was higher in males than in females. In F344 rats, the sum of intestinal expression of the Ugt1a isoform was higher in males in females. Sex hormones are known to regulate expression of some Ugts, which might explain the differences in Ugt expression between sexes.

This was the first study to comprehensively quantify hepatic and intestinal mRNA expression of Ugt isoforms in SD, F344, and Wistar rats, which are used commonly for nonclinical studies. These results would be helpful for pharmaceutical scientists in choosing the strain and sex of rats for future studies.

Kanazawa University

Related Liver Articles:

Immune cell identity crisis: What makes a liver macrophage a liver macrophage?
UC San Diego researchers investigated how a type of immune cell called a macrophage becomes specialized to the liver.
Liver transplants could be redundant with discovery of new liver cell
Researchers at King's College London have used single cell RNA sequencing to identify a type of cell that may be able to regenerate liver tissue, treating liver failure without the need for transplants.
How viable is your liver after you die?
In a paper to be published in a forthcoming issue of TECHNOLOGY, a group of researchers from Harvard Medical School have done a study on the viability of donated livers and its correlation with donor demographics.
Blocking platelets: A possible option to prevent fatty liver disease and liver cancer
Blood platelets which interact with liver cells and immune cells play a major role in the development of fatty liver disease, non-alcoholic fatty liver inflammation and liver cancer, scientists from the German Cancer Research Center (DKFZ) in Heidelberg and from Zurich University and University Hospital have now shown in a publication.
Micro-control of liver metabolism
A new discovery has shed light on small RNAs called microRNAs in the liver that regulate fat and glucose metabolism.
Liver transplants double for alcohol-related liver disease
The proportion of US liver transplants for alcohol-associated liver disease (ALD) has doubled in the last 15 years, in part due to broader acceptance of waiving the mandated period of sobriety before transplants for this population, according to a study by researchers at UC San Francisco, which showed ongoing regional geographic variations in liver transplant rates for ALD patients, whose long-term survival rate is slightly lower than other liver transplant patients.
Liver transplant for alcohol-related liver disease in US
The proportion of liver transplants in the United States for alcohol-associated liver disease increased between 2002 and 2016, with much of the increase associated with a decrease in liver transplant for hepatitis C virus infection because of antiviral therapy.
Real-time detection of cholesterol in liver-on-chip cultures of human liver cells
In a paper to be published in the September/December 2019 issue of TECHNOLOGY, a team of researchers from the IIT, Chicago, has developed a novel microfluidic device for measuring in real-time the cholesterol secreted from liver tissue-chip containing human hepatocytes.
New genetic cause of liver fat uncovered
New research has uncovered genetic variations that may contribute to the development of non-alcoholic fatty liver disease (NAFLD), the leading cause of liver disease.
Sleeping beauty helps identify genes involved in a fatty liver-associated liver cancer
Hepatocellular carcinoma, a deadly form of liver cancer, is increasingly being linked to non-alcoholic fatty liver disease; however, the underlying genetic mechanism of disease progression had remained unknown.
More Liver News and Liver Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.